IRF5 controls both acute and chronic inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 35, 2015, Pages 11001-11006

  Weiss, Miriam ^a   Byrne, Adam J ^a,b   Blazek, Katrina ^a   Saliba, David G ^a   Pease, James E ^b   Perocheau, Dany ^a   Feldmann, Marc ^a   Udalova, Irina A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Acute inflammation; Arthritis; IRF5; Macrophages; Neutrophils

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; CXCL3 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; CHEMOKINE; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; GENE EXPRESSION; LUNG INJURY; MACROPHAGE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ACUTE DISEASE; ANIMAL; CHRONIC DISEASE; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNOVIUM;

ACUTE DISEASE; ANIMALS; CHEMOKINES; CHRONIC DISEASE; INFLAMMATION; INTERFERON REGULATORY FACTORS; MACROPHAGES; MICE; SYNOVIAL MEMBRANE;

EID: 84940975251     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1506254112     Document Type: Article

References (38)

1. Helmick CG, et al.; National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15-25.
2. Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis. Arthritis Rheum 43(12):2619-2633.
3. Smeets TJ, et al. (2001) Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann Rheum Dis 60(6):561-565.
4. Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39(1):115-124.
5. Barrera P, et al. (2000) Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum 43(9):1951-1959.
6. Wright HL, Moots RJ, Edwards SW (2014) The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol 10(10):593-601.
7. Mohr W, Westerhellweg H, Wessinghage D (1981) Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis. Ann Rheum Dis 40(4):396-399.
8. Wittkowski H, et al. (2007) Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis. Ann Rheum Dis 66(8): 1020-1025.
9. Khandpur R, et al. (2013) NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5(178):178ra40.
10. Murray PJ, et al. (2014) Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41(1):14-20.
11. Sieweke MH, Allen JE (2013) Beyond stem cells: Self-renewal of differentiated macrophages. Science 342(6161):1242974.
12. Becher B, et al. (2014) High-dimensional analysis of the murine myeloid cell system. Nat Immunol 15(12):1181-1189.
13. Ericson JA, et al.; ImmGen Consortium (2014) Gene expression during the generation and activation of mouse neutrophils: Implication of novel functional and regulatory pathways. PLoS One 9(10):e108553.
14. Misharin AV, et al. (2014) Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice. Cell Reports 9(2):591-604.
15. Krausgruber T, et al. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12(3):231-238.
16. Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA (2013) IRF5 is a specific marker of inflammatory macrophages in vivo. Mediators Inflamm 2013:245804.
17. Asquith DL, Miller AM, McInnes IB, Liew FY (2009) Animal models of rheumatoid arthritis. Eur J Immunol 39(8):2040-2044.
18. Egan PJ, van Nieuwenhuijze A, Campbell IK, Wicks IP (2008) Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis Rheum 58(12):3720-3729.
19. Parsey MV, Tuder RM, Abraham E (1998) Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 160(2):1007-1013.
20. Dorner T, Lipsky PE (2014) B cells: Depletion or functional modulation in rheumatic diseases. Curr Opin Rheumatol 26(2):228-236.
21. Savitsky DA, Yanai H, Tamura T, Taniguchi T, Honda K (2010) Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc Natl Acad Sci USA 107(22):10154-10159.
22. Boring L, et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100(10): 2552-2561.
23. Nitta N, Tsuchiya T, Yamauchi A, Tamatani T, Kanegasaki S (2007) Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device: TAXIScan. J Immunol Methods 320(1-2):155-163.
24. Colville-Nash P, Lawrence T (2003) Air-pouch models of inflammation and modifications for the study of granuloma-mediated cartilage degradation. Methods Mol Biol 225:181-189.
25. Matute-Bello G, Frevert CW, Martin TR (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295(3):L379-L399.
26. Helft J, et al. (2015) GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells. Immunity 42(6): 1197-1211.
27. Saliba DG, et al. (2014) IRF5:RelA interaction targets inflammatory genes in macrophages. Cell Reports 8(5):1308-1317.
28. Rider P, et al. (2011) IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187(9):4835-4843.
29. Rossol M, Kraus S, Pierer M, Baerwald C, Wagner U (2012) The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 64(3):671-677.
30. Dalmas E, et al. (2015) Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat Med 21(6):610-618.
31. Xu Y, et al. (2012) Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus. J Immunol 188(8):4113-4121.
32. Yang L, Feng D, Bi X, Stone RC, Barnes BJ (2012) Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus. J Immunol 189(7): 3741-3750.
33. Coelho FM, et al. (2008) The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum 58(8):2329-2337.
34. Grespan R, et al. (2008) CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis. Arthritis Rheum 58(7):2030-2040.
35. Kaplan MJ (2013) Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther 15(5):219.
36. Feng D, et al. (2012) Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching. Eur J Immunol 42(6): 1477-1487.
37. Takaoka A, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434(7030):243-249.
38. -/- mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci USA 109(15): E898-E904.